Developer docs
API playgroundTry for free, no card

Search company profiles

Chugai Pharma Germany

Full company profile

uuid000vh88

Namestring
Chugai Pharma Germany
Legal namestring
Chugai Pharma Germany GmbH
Company typeenum
Private
Founded yearint
1925
Descriptiontext

Chugai Pharma Germany GmbH is the German operating subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan), a specialty pharmaceutical company majority-owned by Roche since the 2002 strategic alliance. Headquartered in Frankfurt am Main, the German entity markets prescription pharmaceutical products (including Tocilizumab) in three therapeutic areas — rheumatology, hemophilia, and oncology — through the standard German pharmaceutical distribution chain. Revenue derives from product sales of prescription medicines, with no public disclosure of subsidiary-level financials; the entity's results consolidate into Chugai Pharmaceutical and ultimately into Roche's group accounts.

The company's principal go-to-market asset is its Medical Education portal (chugai-medicaleducation.de), a German-language content platform built on a modular CMS with DocCheck-gated access for verified healthcare professionals. The platform serves rheumatologists, hematologists, oncologists, and Rheumatologische Fachassistenz (RFA) staff with congress summaries (ACR, EULAR, DGRh, ISTH, GTH, EAHAD, ASH), CME-accredited programs (RheumaConnect RZA im Fokus, 7 CME points), podcast series (INtoRHEUMA, WohlDosiert), and condition-specific medical materials. The technology stack includes Matomo analytics, DocCheck identity verification, the IQVIA OneKey HCP database for targeting, and integration with patient-facing resources (Active-A for hemophilia A, Deutsche Rheuma-Liga).

The entity operates three managing directors and a Medical Education team of named scientific staff, and is a member of the German pharma self-regulation bodies AKG and FSA, publishing annual transparency reports on transfers of value to HCPs and patient organizations. Distribution combines direct medical affairs engagement, in-person Qualitätszirkel training events for RFAs, and digital self-service access to educational content, with product distribution handled through authorized German pharmaceutical wholesalers to pharmacies and hospitals.

Short descriptiontext

Chugai Pharma Germany GmbH is the German subsidiary of Chugai Pharmaceutical (Roche Group), marketing specialty prescription drugs in rheumatology, hemophilia, and oncology through a DocCheck-gated Medical Education portal serving German healthcare professionals and Rheumatologische Fachassistenz.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersFrankfort, United States
HQ citystring
Frankfort
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription pharmaceuticals, medical education services, rheumatology treatments, hemophilia therapies, oncology medicines
Industry3 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical product sales (prescription medicines)
TypeHardware Sales
Description

Chugai Pharma Germany operates as the German subsidiary of Chugai Pharmaceutical (Japan). The company markets prescription pharmaceutical products in rheumatology (e.g., Tocilizumab), hemophilia, and oncology. As a subsidiary of Chugai Pharmaceutical (majority-owned by Roche), revenue derives from product sales through the standard pharmaceutical distribution chain in Germany.

chugai-medicaleducation.de
2Medical education and scientific engagement
TypeProfessional Services
Description

Chugai Pharma Germany's Medical Education portal provides scientific and medical information to healthcare professionals as part of the company's medical affairs and scientific engagement activities, supporting product knowledge and clinical practice in aligned therapeutic areas.

chugai-medicaleducation.de
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Technology or R&D, Operations, Supply Chain
Pricing details2 tiers
1Free medical education content for verified medical professionals
ModelFreemiumBilling cadenceAnnual
Notes

Medical education portal content is free to access for verified medical professionals (verified via DocCheck). Product-specific prescribing information is available through the Fachinformationen section.

chugai-medicaleducation.de
2DiGA (digital health applications) — fully reimbursed by statutory health insurers
ModelOtherBilling cadencePay-as-you-go
Notes

DiGA are prescribed by physicians and fully reimbursed by statutory health insurers (gesetzliche Krankenkassen) with no co-payment for patients. They are extrabudgetary (extrabudgetär) for prescribers.

chugai-medicaleducation.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Chugai Pharma Germany GmbH markets and distributes prescription pharmaceutical products in rheumatology, hemophilia, and oncology as the German subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan). The company operates the Medical Education portal (chugai-medicaleducation.de), delivering scientifically curated content, congress summaries, CME-accredited programs, podcasts, and shared decision-making tools to German healthcare professionals and patients. Pharmaceutical products such as Tocilizumab are sold through the standard German pharmaceutical distribution chain.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • CME-accredited programs: RheumaConnect RZA im Fokus offers 7 CME points; Expertise und Innovation webinar offers 2 CME points.
+2 more records
Product overview1 text field

Chugai Pharma Germany's Medical Education platform is a multi-module educational system serving healthcare professionals and patients in three therapeutic areas: Rheumatology, Hemophilia, and Oncology. The core platform provides congress summaries, medical materials, and product information, supplemented by specialized educational programs like RheumaConnect (RZA im Fokus, Journal Club), RFA Qualitätszirkel training, and the Chugai Cancer Summit. Patient-facing resources include the Therapieentscheidungshilfe Hämophilie decision support tool, HaemMotion, and the RA Wegweiser guide. The DiGA service provides information on digital health applications. Key products are distributed through authenticated DocCheck login for healthcare professionals, with some materials available publicly.

Product and service1 record
1Prescription Pharmaceutical Products (Rheumatology, Hemophilia, Oncology)
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Arzneimittel und Kooperation im Gesundheitswesen e.V. (AKG)
Strategic tierCoreTypeOthersAnnounced on2016-01-01
Description

AKG is a German pharmaceutical industry association. Chugai Pharma Germany is a member and participates in the AKG transparency code, publishing annual reports on all financial transfers to medical professionals and patient organizations since 2016.

chugai-medicaleducation.de
2Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. (FSA)
Strategic tierCoreTypeOthersAnnounced on2016-01-01
Description

FSA is the German voluntary self-regulation body for the pharmaceutical industry. Chugai Pharma Germany is a member and participates in the FSA transparency code, publishing annual reports on financial transfers to medical professionals and patient organizations since 2016.

chugai-medicaleducation.de
3Active-A (Leben mit Hämophilie A)
Strategic tierCoreTypeGTM or Marketing Partner
Description

Active-A is a patient-facing website for people living with hemophilia A, managed or supported by Chugai Pharma Germany. It provides current reports, blog posts, and information from patients with hemophilia A, serving as a patient engagement and support channel linked from the Chugai Medical Education portal.

chugai-medicaleducation.de
Strategic tierCoreTypeGTM or Marketing Partner
Description

Deutsche Rheuma-Liga is Germany's largest national self-help organization for people with rheumatic diseases, referenced on Chugai's patient information pages as a recommended resource for patients. The partnership supports patient referrals and disease awareness in rheumatology.

5Fachverband Rheumatologische Fachassistenz e.V.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The professional association for rheumatological specialist assistants (RFAs) in Germany. Chugai partners with this association through the RheumaConnect and Qualitätszirkel programs, with Patricia Steffens-Korbanka serving as 2nd Chair of the association and co-hosting Chugai's WohlDosiert podcast series.

chugai-medicaleducation.de
Strategic tierSupportingTypeTechnology or Integration
Description

Chugai Pharma Germany uses IQVIA's OneKey database containing current master, contact, and specialization data for medical professionals in Germany. Data is used for customer relationship management and HCP targeting, based on legitimate interest under Art. 6(1)(f) GDPR.

Strategic tierCoreTypeTechnology or Integration
Description

DocCheck provides medical professional verification (Login) for the Chugai Medical Education portal, ensuring that prescription drug information is accessible only to verified members of medical professions, in compliance with German pharmaceutical advertising regulations.

8KITASATO (Online Symposia Platform)
Strategic tierMinorTypeOthers
Description

Chugai Medical Education references KITASATO as a platform for hosting online symposia, as mentioned in the News section of the portal where new online symposia are announced.

chugai-medicaleducation.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chugai Pharma Germany

Specialty Pharmaceuticalschugai-medicaleducation.de

Chugai Pharma Germany GmbH is the German subsidiary of Chugai Pharmaceutical (Roche Group), marketing specialty prescription drugs in rheumatology, hemophilia, and oncology through a DocCheck-gated Medical Education portal serving German healthcare professionals and Rheumatologische Fachassistenz.

What Chugai Pharma Germany does

Chugai Pharma Germany GmbH is the German operating subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan), a specialty pharmaceutical company majority-owned by Roche since the 2002 strategic alliance. Headquartered in Frankfurt am Main, the German entity markets prescription pharmaceutical products (including Tocilizumab) in three therapeutic areas — rheumatology, hemophilia, and oncology — through the standard German pharmaceutical distribution chain. Revenue derives from product sales of prescription medicines, with no public disclosure of subsidiary-level financials; the entity's results consolidate into Chugai Pharmaceutical and ultimately into Roche's group accounts.

The company's principal go-to-market asset is its Medical Education portal (chugai-medicaleducation.de), a German-language content platform built on a modular CMS with DocCheck-gated access for verified healthcare professionals. The platform serves rheumatologists, hematologists, oncologists, and Rheumatologische Fachassistenz (RFA) staff with congress summaries (ACR, EULAR, DGRh, ISTH, GTH, EAHAD, ASH), CME-accredited programs (RheumaConnect RZA im Fokus, 7 CME points), podcast series (INtoRHEUMA, WohlDosiert), and condition-specific medical materials. The technology stack includes Matomo analytics, DocCheck identity verification, the IQVIA OneKey HCP database for targeting, and integration with patient-facing resources (Active-A for hemophilia A, Deutsche Rheuma-Liga).

The entity operates three managing directors and a Medical Education team of named scientific staff, and is a member of the German pharma self-regulation bodies AKG and FSA, publishing annual transparency reports on transfers of value to HCPs and patient organizations. Distribution combines direct medical affairs engagement, in-person Qualitätszirkel training events for RFAs, and digital self-service access to educational content, with product distribution handled through authorized German pharmaceutical wholesalers to pharmacies and hospitals.

Chugai Pharma Germany firmographics

Firmographics
Name
Chugai Pharma Germany
Legal name
Chugai Pharma Germany GmbH
Website
https://chugai-medicaleducation.de
Company type
Private
Founded year
1925
Operating status
Operating
Short description
Chugai Pharma Germany GmbH is the German subsidiary of Chugai Pharmaceutical (Roche Group), marketing specialty prescription drugs in rheumatology, hemophilia, and oncology through a DocCheck-gated Medical Education portal serving German healthcare professionals and Rheumatologische Fachassistenz.
Ownership category
akta.pro rank

Chugai Pharma Germany industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

Keywords

  • Prescription pharmaceuticals
  • Medical education services
  • Rheumatology treatments
  • Hemophilia therapies
  • Oncology medicines

Where Chugai Pharma Germany is headquartered

Location

Headquarters

HQ city
Frankfort
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Chugai Pharma Germany business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations, Supply Chain

Revenue model

  1. Pharmaceutical product sales (prescription medicines): Chugai Pharma Germany operates as the German subsidiary of Chugai Pharmaceutical (Japan). The company markets prescription pharmaceutical products in rheumatology (e.g., Tocilizumab), hemophilia, and oncology. As a subsidiary of Chugai Pharmaceutical (majority-owned by Roche), revenue derives from product sales through the standard pharmaceutical distribution chain in Germany.
  2. Medical education and scientific engagement: Chugai Pharma Germany's Medical Education portal provides scientific and medical information to healthcare professionals as part of the company's medical affairs and scientific engagement activities, supporting product knowledge and clinical practice in aligned therapeutic areas.

Pricing tiers

ModelBillingPrice
FreemiumAnnualFree medical education content for verified medical professionals
OtherPay-as-you-goDiGA (digital health applications) — fully reimbursed by statutory health insurers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Chugai Pharma Germany product offering

Product offering

Core offering

Chugai Pharma Germany GmbH markets and distributes prescription pharmaceutical products in rheumatology, hemophilia, and oncology as the German subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan). The company operates the Medical Education portal (chugai-medicaleducation.de), delivering scientifically curated content, congress summaries, CME-accredited programs, podcasts, and shared decision-making tools to German healthcare professionals and patients. Pharmaceutical products such as Tocilizumab are sold through the standard German pharmaceutical distribution chain.

Product overview

Chugai Pharma Germany's Medical Education platform is a multi-module educational system serving healthcare professionals and patients in three therapeutic areas: Rheumatology, Hemophilia, and Oncology. The core platform provides congress summaries, medical materials, and product information, supplemented by specialized educational programs like RheumaConnect (RZA im Fokus, Journal Club), RFA Qualitätszirkel training, and the Chugai Cancer Summit. Patient-facing resources include the Therapieentscheidungshilfe Hämophilie decision support tool, HaemMotion, and the RA Wegweiser guide. The DiGA service provides information on digital health applications. Key products are distributed through authenticated DocCheck login for healthcare professionals, with some materials available publicly.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prescription Pharmaceutical Products (Rheumatology, Hemophilia, Oncology)

Quantifiable outcome

  • CME-accredited programs: RheumaConnect RZA im Fokus offers 7 CME points; Expertise und Innovation webinar offers 2 CME points.
  • +2 more outcomes

Companies that use Chugai Pharma Germany

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles3 records

Chugai Pharma Germany technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Chugai Pharma Germany partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, supporting and minor.

  • Arzneimittel und Kooperation im Gesundheitswesen e.V. (AKG)coreOthers · 1 January 2016AKG is a German pharmaceutical industry association. Chugai Pharma Germany is a member and participates in the AKG transparency code, publishing annual reports on all financial transfers to medical professionals and patient organizations since 2016.
  • Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. (FSA)coreOthers · 1 January 2016FSA is the German voluntary self-regulation body for the pharmaceutical industry. Chugai Pharma Germany is a member and participates in the FSA transparency code, publishing annual reports on financial transfers to medical professionals and patient organizations since 2016.
  • Active-A (Leben mit Hämophilie A)coreGTM or Marketing PartnerActive-A is a patient-facing website for people living with hemophilia A, managed or supported by Chugai Pharma Germany. It provides current reports, blog posts, and information from patients with hemophilia A, serving as a patient engagement and support channel linked from the Chugai Medical Education portal.
  • Deutsche Rheuma-LigacoreGTM or Marketing PartnerDeutsche Rheuma-Liga is Germany's largest national self-help organization for people with rheumatic diseases, referenced on Chugai's patient information pages as a recommended resource for patients. The partnership supports patient referrals and disease awareness in rheumatology.
  • Fachverband Rheumatologische Fachassistenz e.V.coreStrategic or Co-development PartnerThe professional association for rheumatological specialist assistants (RFAs) in Germany. Chugai partners with this association through the RheumaConnect and Qualitätszirkel programs, with Patricia Steffens-Korbanka serving as 2nd Chair of the association and co-hosting Chugai's WohlDosiert podcast series.
  • IQVIA Commercial GmbH & Co. OHGsupportingTechnology or IntegrationChugai Pharma Germany uses IQVIA's OneKey database containing current master, contact, and specialization data for medical professionals in Germany. Data is used for customer relationship management and HCP targeting, based on legitimate interest under Art. 6(1)(f) GDPR.
  • DocCheck Medical Services GmbHcoreTechnology or IntegrationDocCheck provides medical professional verification (Login) for the Chugai Medical Education portal, ensuring that prescription drug information is accessible only to verified members of medical professions, in compliance with German pharmaceutical advertising regulations.
  • KITASATO (Online Symposia Platform)minorOthersChugai Medical Education references KITASATO as a platform for hosting online symposia, as mentioned in the News section of the portal where new online symposia are announced.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Chugai Pharma Germany competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Chugai Pharma Germany compliance and trust

Trust signal

Compliance2 records

Chugai Pharma Germany financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chugai Pharma Germany leadership team

Management profile

Number of profiles

Profiles6 records

Chugai Pharma Germany funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chugai Pharma Germany M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chugai Pharma Germany

What does Chugai Pharma Germany do?

Chugai Pharma Germany GmbH markets and distributes prescription pharmaceutical products in rheumatology, hemophilia, and oncology as the German subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan). The company operates the Medical Education portal (chugai-medicaleducation.de), delivering scientifically curated content, congress summaries, CME-accredited programs, podcasts, and shared decision-making tools to German healthcare professionals and patients. Pharmaceutical products such as Tocilizumab are sold through the standard German pharmaceutical distribution chain.

Is Chugai Pharma Germany a public or private company?

Chugai Pharma Germany is a private company. It is classified as corporate owned and is currently operating.

When was Chugai Pharma Germany founded?

Chugai Pharma Germany was founded in 1925.

Where is Chugai Pharma Germany based?

Chugai Pharma Germany is headquartered in Frankfort, United States, in the North America region.

How does Chugai Pharma Germany make money?

Two revenue lines are on record. Pharmaceutical product sales (prescription medicines) is the primary driver. The others are medical education and scientific engagement.

Does Chugai Pharma Germany have an API?

No public API is recorded for Chugai Pharma Germany.

What industry is Chugai Pharma Germany in?

Chugai Pharma Germany's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales